Analytical Verification Every batch undergoes Mile High Compounds comprehensive analytical protocol: High-Performance Liquid Chromatography (HPLC) for purity quantification of each component Mass Spectrometry (MS) for molecular weight and identity confirmation of both peptides 14-day sterility testing Endotoxin analysis 4-vial batch conformity verification statistically robust consistency testing across each production batch, exceeding the industry-standard single-vial sampling approach Heavy metal screening for lead, arsenic, cadmium, mercury, and additional trace metals Container and seal integrity verification Batch-specific Certificates of Analysis (COAs) accompany every order, documenting full testing results for both component peptides
The downstream effects on members are significant and often avoidable: Access barriers created by prior authorization can delay or prevent treatment for members who need it Members without clinical support are more likely to abandon therapy, driving worse outcomes and higher costs Formularies designed around rebates rather than clinical value can limit access to the most appropriate treatments Proactive member engagement at the point of initiation meaningfully improves adherence and outcomes PBM's role in managing specialty drugs
And when Novo Nordisk faced production issues, the decision to choose Eli Lilly's Mounjaro and Zepbound over Novo Nordisk's Wagovy became even easier
Key lessons for ethical and affordable access to GLP-1 drugs like Ozempic and Wegovy
Amino Acids Essential for muscle recovery, metabolism, and cognitive function
Standard semaglutide or tirzepatide pens are available with a fixed strength
